Regulation of alternative splicing and polyadenylation in cancer, therapeutic modulation of RNA processing, antisense technology development, induction of natural antagonists of oncogenes, manipulation of Receptor Tyrosine Kinase (e.g. EGFR, VEGFR, MET, etc.) and STAT3 signaling pathways in cancer